EUVIMEDEUVIMED entdecken
Open Access

B lymphocyte protein factories produced by hematopoietic stem cell gene editing

Harald Hartweger iD, Chiara Ruprecht iD, Kai-Hui Yao, Philippe Laffont, Gabriella Lima Dos Reis iD, Pengcheng Zhou iD, Thomas Hägglöf iD, Laurine Binet iD, Maximilian Loewe iD, Jun P Hong iD, Tianli Xiao iD, Esen Sefik iD und 17 weitere

Science · 16.04.2026 · 392 (6795)

DOI: 10.1126/science.adz8994 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science, erschienen am 16.04.2026. Verfasst von Harald Hartweger und 28 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Molecular Immunology, Rockefeller University, New York, NY, USA. Hauptthemen laut MEDLINE: B-Lymphocytes, Gene Editing, Hematopoietic Stem Cells. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 75 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, Bill & Melinda Gates Foundation, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Long-term in vivo production of therapeutic proteins and development of vaccines that elicit protective levels of broadly neutralizing antibodies (bNAbs) against major pathogens face challenges. In this study, we report on an alternative gene editing approach using small numbers of hematopoietic stem and progenitor cells (HSPCs) to direct long-term, high-level expression of antibodies or cargo proteins. In mice, edited B lymphocytes derived from transplanted HSPCs were activated by cognate antigen, underwent clonal expansion, and developed into specific antibody-synthesizing or cargo protein–synthesizing plasma cells. These cells produced long-lasting, therapeutic levels of serum antibody against HIV-1, malaria, or an anti-influenza virus bNAb that mediated universal protection from heterologous lethal challenge. Our data provide a paradigm for cell therapy approaches to prevent or treat disease using self-amplifying B cell protein factories.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

B-LymphocytesGene EditingHematopoietic Stem CellsAnimalsMiceBroadly Neutralizing AntibodiesCRISPR-Cas SystemsHematopoietic Stem Cell TransplantationHIV AntibodiesHIV-1MalariaMice, Inbred C57BLOrthomyxoviridae InfectionsPlasma CellsPrecursor Cells, B-LymphoidAntibodies, Protozoan

Substanzen

Broadly Neutralizing AntibodiesHIV AntibodiesAntibodies, Protozoan

Autor:innen und Institutionen

  • Laboratory of Molecular Immunology, Rockefeller University, New York, NY, USA.
  • Department of Immunobiology, Yale School of Medicine, New Haven, CT, USA.
  • Howard Hughes Medical Institute, Yale School of Medicine, New Haven, CT, USA.
  • Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.
  • Vector Biology Unit, Max Planck Institute for Infection Biology, Berlin, Germany.
  • Drukier Institute for Children's Health, Department of Pediatrics, Weill Cornell Medicine, New York, NY, USA.

ORCID-Profile: Harald Hartweger, Chiara Ruprecht, Gabriella Lima Dos Reis, Pengcheng Zhou, Thomas Hägglöf, Laurine Binet, Maximilian Loewe, Jun P Hong, Tianli Xiao, Esen Sefik, Anna Gazumyan, Michael S Seaman, Giulia Costa, Jordan Clark, Sachie Kanatani, Patrick C Wilson, Florian Krammer, Elena A Levashina, Jean-Philippe Julien, Hedda Wardemann, Photini Sinnis, Leonidas Stamatatos, Richard A Flavell, Michel C Nussenzweig

Förderung

  • NIAID NIH HHS
  • Bill & Melinda Gates Foundation
  • National Institutes of Health
  • Hemophilia Association of New York
  • Canada Research Chair Program
  • Bill and Melinda Gate Foundation
  • Johns Hopkins Malaria Research Institute Fellowship
  • Stavros Niarchos Foundation Institute for Global Infectious Disease Research

Zitieren

APA

Hartweger, H., Ruprecht, C., Yao, K. H., Laffont, P., Lima Dos Reis, G., Zhou, P., Hägglöf, T., Binet, L., Loewe, M., Hong, J. P., Xiao, T., Sefik, E., Hernandez, B., Gazumyan, A., Jankovic, M., Seaman, M. S., Costa, G., Nelson, S. A., Clark, J., …, & Nussenzweig, M. C. (2026). B lymphocyte protein factories produced by hematopoietic stem cell gene editing. Science, 392(6795). https://doi.org/10.1126/science.adz8994

Vancouver

Hartweger H, Ruprecht C, Yao KH, Laffont P, Lima Dos Reis G, Zhou P, et al. B lymphocyte protein factories produced by hematopoietic stem cell gene editing. Science. 2026;392(6795). doi:10.1126/science.adz8994

BibTeX
@article{Hartweger2026,
  author = {Hartweger, Harald and Ruprecht, Chiara and Yao, Kai-Hui and Laffont, Philippe and Lima Dos Reis, Gabriella and Zhou, Pengcheng and Hägglöf, Thomas and Binet, Laurine and Loewe, Maximilian and Hong, Jun P and Xiao, Tianli and Sefik, Esen and Hernandez, Brianna and Gazumyan, Anna and Jankovic, Mila and Seaman, Michael S and Costa, Giulia and Nelson, Sean A and Clark, Jordan and Kanatani, Sachie and Wilson, Patrick C and Krammer, Florian and Levashina, Elena A and Julien, Jean-Philippe and Wardemann, Hedda and Sinnis, Photini and Stamatatos, Leonidas and Flavell, Richard A and Nussenzweig, Michel C},
  title = {B lymphocyte protein factories produced by hematopoietic stem cell gene editing},
  journal = {Science},
  year = {2026},
  volume = {392},
  number = {6795},
  doi = {10.1126/science.adz8994}
}
Kostenlos starten →